Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Recro Pharma Inc (NASDAQ:REPH)

9.82
Delayed Data
As of Dec 11
 +0.17 / +1.76%
Today’s Change
5.81
Today|||52-Week Range
10.59
+21.84%
Year-to-Date
No recent news for Recro Pharma Inc.

Today’s Trading

Previous close9.65
Today’s open9.70
Day’s range9.56 - 10.04
Volume118,371
Average volume (3 months)93,264
Market cap$187.8M
Data as of 4:00pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-1,442.86%
Earnings growth (this year)+21.63%
Earnings growth (next 5 years)--
Revenue growth (last year)+33.46%
P/E ratioNM
Price/Sales1.25
Price/Book2.61

Competitors

 Today’s
change
Today’s
% change
TRVNTrevena Inc+0.16+10.53%
VCELVericel Corp+0.13+2.65%
PPHMPeregrine Pharmaceut...+0.09+1.71%
RDHLRedhill Biopharma Lt...-0.02-0.43%
Data as of 4:00pm ET, 12/11/2017

Financials

Next reporting dateMarch 6, 2018
EPS forecast (this quarter)-$0.85
Annual revenue (last year)$69.3M
Annual profit (last year)-$30.2M
Net profit margin-43.56%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Gerri Henwood
Chief Financial Officer
Michael Celano
Corporate headquarters
Malvern, Pennsylvania

Forecasts